Max Planck Society

Noster research: NOSTER and Science Microbiome Prize Symposium and Award Ceremony Honor Young Researchers' Novel Contributions

Retrieved on: 
星期四, 十月 26, 2023
Research, Sport, University of Newcastle, Health, Shosei-en Garden, Max Planck Institute for Biology, Max Planck Institute for Developmental Biology, 1916 American Grand Prize, AAAS, Chair, University of Pennsylvania, Drug development, Fellow of the American Association for the Advancement of Science, Disease, Higashi Hongan-ji, Partnership, University, Max Planck Society, Managing editor, Prize, Pharmaceutical industry, Physiology, Science, Medicine

KYOTO, Japan, Oct. 26, 2023 /PRNewswire/ -- NOSTER Inc and Science, the prestigious academic journal, joined forces to host the NOSTER and Science Microbiome Prize Symposium and the 4th prize award ceremony on October 5th and 6th in Kyoto, Japan.

Key Points: 
  • KYOTO, Japan, Oct. 26, 2023 /PRNewswire/ -- NOSTER Inc and Science, the prestigious academic journal, joined forces to host the NOSTER and Science Microbiome Prize Symposium and the 4th prize award ceremony on October 5th and 6th in Kyoto, Japan.
  • The NOSTER & Science Microbiome Prize rewards innovative research from young investigators studying how microbiota has the potential to contribute to our understanding of health and disease, or to guide novel therapeutic interventions.
  • The Japanese company NOSTER established this award in 2020 in partnership with Science and its publisher, the American Association for the Advancement of Science (AAAS).
  • NOSTER remains committed to supporting young scientists through this award and aims to contribute to breakthrough drug development driven by microbiome research.

EQS-News: Study proves: Cold plasma is a quantum leap for the treatment of chronic wounds

Retrieved on: 
星期二, 十月 17, 2023
Perception, Max Planck Society, Hope, Plasma, LKH, KAP, Trial of the century, Education, PH, Synthetic control method, Wound healing, Morfill, Gesellschaft mit beschränkter Haftung, Supervisory board, Research, Publication, SWT, Skin, VAS, Max Planck Institute for Nuclear Physics, Observation, Healing, Patient, Quality of life, Federal Ministry of Health (Germany), Nursing, Pain

Hamburg / Munich - 06.10.2023 - For people with chronic and non-healing wounds, there is a solution: cold atmospheric plasma (KAP).

Key Points: 
  • Hamburg / Munich - 06.10.2023 - For people with chronic and non-healing wounds, there is a solution: cold atmospheric plasma (KAP).
  • As proven by a pilot study commissioned by Munich-based terraplasma medical GmbH, a company of the Hamburg-based Viromed Group, the innovative wound and skin treatment of the cold plasma technique is superior to standard wound treatment (SWT).
  • The study used the mobile, CE-certified and painless cold plasma device plasma care® from terraplasma medical.
  • The aim of treating (infected) chronic and acute wounds with KAP is to inactivate microorganisms, including multi-resistant pathogens, and to stimulate wound healing.

Nobel prize in physics awarded for work unveiling the secrets of electrons

Retrieved on: 
星期二, 十月 3, 2023
Lund University, Ohio State University, Electron, Nanoparticle, Max Planck Institute of Quantum Optics, Agostini, Electronics, Phenomenon, Nobel Prize in Physics, ARD International Music Competition, Nobel Prize, Electricity, Cancer, Light, Research, Achievement, Science, Engineering, Nobel, Physics, Max Planck Society, Microscope, Medical imaging, Computer data storage, Electric motor

The 2023 Nobel prize in physics has been awarded to a trio of scientists for pioneering tools used to study the world of electrons.

Key Points: 
  • The 2023 Nobel prize in physics has been awarded to a trio of scientists for pioneering tools used to study the world of electrons.
  • This year’s three Nobel physics laureates demonstrated a way to create extremely short pulses of light in order to investigate processes that involve electrons.
  • Changes in electrons typically occur in a few tenths of an “attosecond”, which is a billionth of a billionth of a second.
  • The award of the Nobel prize in this field inspires us to redouble our efforts to break novel ground.

Blocking Abnormal Stem Cell Signal during Aging Lessens Related Bone Loss

Retrieved on: 
星期三, 九月 27, 2023
Skeleton, Osteoporosis, Bone marrow, Adipocyte, Doctor of Philosophy, National Institutes of Health, Bangladesh Technical Education Board, B cell, Pharmacotherapy, Protein, MD, Ageing, Orthopedic surgery, Disease, Tissue, University, Therapy, NYU, Research, University college, Osteoblast, Nicastrin, Fracture, Heterochromatin, DNA, Cancer, New York University Grossman School of Medicine, Multimedia, Cell, Steatosis, Max Planck Institute for Molecular Biomedicine, Miami Shores, Florida, Max Planck Society, Laura, Patricia, RNA, NYU Langone Health, Morphogenesis, Cell biology, Mouse, New York University College of Dentistry, Gene, Mobile phone, Phosphorus, Dentistry, EFF, SSPC, Pathology, Notch, Nature, Isaac Leucht

The study, led by researchers from NYU Grossman School of Medicine, found that blocking the signaling pathway, called Notch, in aging skeletal stem cells caused a "massive increase" in bone mass and restored lost bone-healing ability during aging.

Key Points: 
  • The study, led by researchers from NYU Grossman School of Medicine, found that blocking the signaling pathway, called Notch, in aging skeletal stem cells caused a "massive increase" in bone mass and restored lost bone-healing ability during aging.
  • The study results revolve around immature stem cells, which have the capacity to mature into more than one cell type.
  • Aging is known to come with loss of the ability of stem cells to become bone-making cells, with related skeletal deterioration among the most common causes of age-associated impairment.
  • "Our newly gained knowledge opens potential therapeutic avenues to overcome age-related bone loss by manipulating down-stream effectors for Notch signaling in these stem cells."

VERSES AI Q3 Corporate Update

Retrieved on: 
星期四, 九月 21, 2023
Artificial general intelligence, Learning, Intellectual property, AGI, Open Government Partnership, Civil service commission, Face, Spatial, Electrical engineering technology, University, Electronics, MIT, Aircraft, Pharmacy, International Union of Physiological Sciences, Okazaki, Electricity, Judgement, Government, Science, Organization, IEEE, Trust, National Institute for Physiological Sciences, Japan, Artificiality, Artificial intelligence, Growth, Dentons, Ecosystem, AI, Research, Society, Gartner, Imperial College London, Max Planck Society, CBOE, European Commission, Legislation, Mobile phone, Medical device, Online shopping, Risk management, Points of the compass

VANCOUVER, British Columbia, Sept. 21, 2023 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:VERS) (OTCQX:VRSSF) ("VERSES'' or the "Company”), a cognitive computing company specializing in the next generation of artificial intelligence, announced the rollout of its next-generation intelligent software platform in its Q3 Corporate Update.

Key Points: 
  • VANCOUVER, British Columbia, Sept. 21, 2023 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:VERS) (OTCQX:VRSSF) ("VERSES'' or the "Company”), a cognitive computing company specializing in the next generation of artificial intelligence, announced the rollout of its next-generation intelligent software platform in its Q3 Corporate Update.
  • Government Partnerships: VERSES was selected by the European Commission to develop AI governance for autonomous drone activities and became part of dAIEDGE, a network of excellence for Edge AI (https://aiatedge.eu).
  • With this list of milestones, VERSES demonstrates its commitment to a smarter and safer future for AI.
  • To read the complete Corporate Update, click here: www.verses.ai/blogs/corporate-update
    This press release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable securities legislation.

Scinai Immunotherapeutics Innovative Plaque Psoriasis Treatment Shows Encouraging Preclinical Results

Retrieved on: 
星期三, 九月 13, 2023
China Biologic Products, IBN, Injection, Plaque, Asthma, NVS, Therapy, Dermis, AMD, University Medical Center, Hook effect, I&I, 3D, European Medicines Agency, COVID-19, Clinical trial, Infection, Inflammation, IL-17A, Psoriasis, EMA, VHH, LLY, UCB, Novartis, Patient, Lilly, Risk, Max Planck Institute for Multidisciplinary Sciences, Brussels Stock Exchange, UMG, Mab, CCL20, CXCL1, AF, Research, Moonlake, NYSE, Max Planck Society, Skin, Autoimmunity, Disease, Pharmaceutical industry, Vaccine

JERUSALEM, Sept. 13, 2023 (GLOBE NEWSWIRE) -- via IBN – Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases, today announces encouraging results in a preclinical study of Scinai’s anti‑interleukin 17 (IL‑17) NanoAbs as a treatment for plaque psoriasis.

Key Points: 
  • Results from ex-vivo study in human psoriatic skin anticipated in Q4 2023; In-vivo animal study results anticipated in early 2024
    JERUSALEM, Sept. 13, 2023 (GLOBE NEWSWIRE) -- via IBN – Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases, today announces encouraging results in a preclinical study of Scinai’s anti‑interleukin 17 (IL‑17) NanoAbs as a treatment for plaque psoriasis.
  • These results suggest NanoAbs’ therapeutic potential to relieve symptoms of plaque psoriasis.
  • Research shows that targeting IL-17F isoform in addition to IL-17A provides higher efficacy in treating plaque psoriasis.
  • Scinai recently started to evaluate the anti-IL-17 NanoAbs in a full human skin model induced for plaque psoriasis to evaluate the effective dose and schedule of treatment, with in-vivo animal studies anticipated in early 2024.

BiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd. to Reflect New Focus on Development of Novel Inflammation and Immunology (I&I) Biological Therapeutics

Retrieved on: 
星期三, 九月 6, 2023
GMP, Inhalation, Asthma, IPO, Drug development, Failure, Half-life, University Medical Center, COVID-19, BVXV, WLA, Psoriasis, Science, HS, VHH, Hidradenitis suppurativa, CDMO, Max Planck Institute for Multidisciplinary Sciences, CGMP, Risk, UMG, CUSIP, Hook effect, Max Planck Society, IBN, Safety, Fine chemical, Vaccine, Pharmaceutical industry, Medicine

In the past two years, the Company has substantially revamped its senior management team and pharmaceuticals development programs and recently announced its expansion into the CDMO business under the banner Scinai Bioservices.

Key Points: 
  • In the past two years, the Company has substantially revamped its senior management team and pharmaceuticals development programs and recently announced its expansion into the CDMO business under the banner Scinai Bioservices.
  • NanoAbs are alpaca-derived recombinant variable domain of heavy-chain-only antibodies and are also known as nanobodies or VHH antibodies.
  • This process can often take many years, cost hundreds of millions of dollars, yet nevertheless incurs a high rate of failure.
  • We have a sharp commercial focus and a pipeline with blockbuster potential, steeped in science, strong leadership and an expertly designed technological base.

NIST publish the highly anticipated draft standards for Quantum-Safe cryptography, supported by PQShield

Retrieved on: 
星期四, 八月 24, 2023
CRYSTALS, Max Planck Institute for Security and Privacy, NIST, Institute of Mathematics, HCLTech, University of Oxford, PQC, Partnership, Lattice Semiconductor, OpenSSL, AMD, National Cybersecurity Center of Excellence, Internet Engineering Task Force, Research, GSMA, Computer, Security, C, Radboud University Nijmegen, World Economic Forum, Algorithm, Oxford University Innovation, FIPS, Tata Consultancy Services, Microchip Technology, Growth, British, ANSSI, Collins Aerospace, TLS termination proxy, Quantum, AWS, Max Planck Society, Software, Medical device, Microscope, Cryptocurrency, Defense, Mathematics, Privacy

Following this, the draft standards will likely become the global benchmark for quantum-resistant cybersecurity across the world in 2024.

Key Points: 
  • Following this, the draft standards will likely become the global benchmark for quantum-resistant cybersecurity across the world in 2024.
  • The rise of quantum computers has led to an urgent need for new cryptographic standards to safeguard global privacy and data.
  • Dr Ali El Kaafarani, PQShield's founder and CEO, says: The release of the draft standards marks a significant turning point for PQShield and the entire cryptographic community.
  • NIST's new draft standards provide this assurance and a framework that allows everyone to move forward.

NIST publish the highly anticipated draft standards for Quantum-Safe cryptography, supported by PQShield

Retrieved on: 
星期四, 八月 24, 2023
CRYSTALS, Max Planck Institute for Security and Privacy, NIST, Institute of Mathematics, HCLTech, University of Oxford, PQC, Partnership, Lattice Semiconductor, OpenSSL, AMD, National Cybersecurity Center of Excellence, Internet Engineering Task Force, Research, GSMA, Computer, Security, C, Radboud University Nijmegen, World Economic Forum, Algorithm, Oxford University Innovation, FIPS, Tata Consultancy Services, Microchip Technology, Growth, British, ANSSI, Collins Aerospace, TLS termination proxy, Quantum, AWS, Max Planck Society, Software, Medical device, Microscope, Cryptocurrency, Defense, Mathematics, Privacy

Following this, the draft standards will likely become the global benchmark for quantum-resistant cybersecurity across the world in 2024.

Key Points: 
  • Following this, the draft standards will likely become the global benchmark for quantum-resistant cybersecurity across the world in 2024.
  • The rise of quantum computers has led to an urgent need for new cryptographic standards to safeguard global privacy and data.
  • Dr Ali El Kaafarani, PQShield's founder and CEO, says: The release of the draft standards marks a significant turning point for PQShield and the entire cryptographic community.
  • NIST's new draft standards provide this assurance and a framework that allows everyone to move forward.

New research reveals that Ötzi the iceman was bald and probably from a farming family – what else can DNA uncover?

Retrieved on: 
星期四, 八月 24, 2023
DNA, Hair, Human, University, Diet, South Tyrol Museum of Archaeology, Body composition, Guanine, Genetics, Iceman, Hair loss, HERC2, MC1R, Thymine, Adenine, Permafrost, Research, Temperature, Cell, Metallurgy during the Copper Age in Europe, Genetic code, Chalcolithic, Cytosine, Portrait, Twin, Chromosome, Max Planck Institute for Evolutionary Anthropology, Battle, University of Leicester, Death, Environment, Gene, Max Planck Society, Skin, Genome, Disease, Medicinal plants, Computer data storage, Tourism, Phosphorus, Dietary supplement, Cosmetics, Archaeology

This amazing find would subsequently become known as Ötzi the Iceman.

Key Points: 
  • This amazing find would subsequently become known as Ötzi the Iceman.
  • His body and belongings were extensively studied, prompting numerous questions: what was he doing here?
  • His unique preservation enabled the sequencing of Ötzi’s whole genome – the complete “instruction booklet” for building a human.
  • But it was enough for a team led by Turi King at the University of Leicester to extract fragments of DNA from them.

Crime scene samples

    • Sequencing a genome, which comprises billions of DNA bases, enables scientists to evaluate regions of the human genome that contribute to appearance.
    • For more than 30 years, forensic scientists have looked at specific highly variable regions in DNA to match these to crime scene samples, or to relatives of a suspect or victim.
    • So how likely is it that DNA from such a sample could accurately paint a picture of me?
    • Can forensic scientists build a kind of identikit photo from a crime scene DNA sample?
    • Hair colour can be predicted from DNA, but darker shades of hair are more accurately predicted than blonde hair.

Environmental factors

    • Commercially sold laboratory kits such as Hirisplex can simultaneously evaluate several DNA regions to predict the hair and eye colour from a biological sample.
    • However, unlike eye colour, hair colour prediction from DNA is only of value until midlife, when the natural processes of ageing lead to greying or white hair.
    • These processes also lead to hair loss in some people and more than 300 gene variants have been linked to baldness.
    • More representative data from the rest of the world will therefore enhance studies in forensic archaeology, such as the Ötzi research.